Get the latest tech news
America's FDA Approves First New Drug for Schizophrenia in Over 30 Years
Thursday America's Food and Drug Administration approved Cobenfy, "the first new drug to treat people with schizophrenia in more than 30 years," reports ABC News: Most schizophrenia medications, broadly known as antipsychotics, work by changing dopamine levels, a brain chemical that affects mood, m...
Thursday America's Food and Drug Administration approved Cobenfy, "the first new drug to treat people with schizophrenia in more than 30 years," reports ABC News: Most schizophrenia medications, broadly known as antipsychotics, work by changing dopamine levels, a brain chemical that affects mood, motivation, and thinking [according to Jelena Kunovac, MD, a board-certified psychiatrist and adjunct assistant professor at the University of Nevada, Las Vegas, in the Department of Psychiatry]. By focusing on acetylcholine instead of dopamine, Cobenfy may reduce schizophrenia symptoms while avoiding common side effects like weight gain, drowsiness and movement disorders, clinical trials suggest. In clinical trials, only 6% of patients stopped taking Cobenfy due to side effects, noted Dr. Samit Hirawat, chief medical officer at Bristol Myers Squibb.
Or read this on Slashdot
